The pharmacology of bosentan
Authors:
- 1 July 1998
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 7 (7) , 1173-1192
Abstract
This article describes the pharmacological properties and the overall preclinical and clinical profiling of bosentan (Ro 47-0203), a non-peptide endothelin receptor antagonist with oral activity. Bosentan is a combined and competitive antagonist of both ETA and ETB receptors that is selective for the endothelin system. In vitro and in vivo, bosentan potently antagonises the vascular response elicited by the endothelins. Preclinical efficacy is demonstrated in a variety of pathological models including pulmonary and essential hypertension, renal failure of ischaemic and nephrotic origin and cerebral vasospasm following subarachnoid haemorrhage. Effects are particularly marked in experimental models of heart failure (HF) where bosentan acts as a potent vasodilator that improves overall left ventricular performance. After chronic treatment, bosentan also improves survival in rats with HF. As a result of the first encouraging clinical results that show pulmonary and systemic vasodilation, long-term studies are ongoing in the treatment of congestive heart failure (CHF).Keywords
This publication has 98 references indexed in Scilit:
- Endothelins and endothelin receptor antagonists: Binding to plasma proteinsLife Sciences, 1996
- Separable Binding Sites for the Natural Agonist Endothelin-1 and the Non-Peptide Antagonist Bosentan on Human Endothelin-A ReceptorsEuropean Journal of Biochemistry, 1995
- Characterization of Endothelin Receptors Mediating Rat Hepatic Stellate Cell ContractionBiochemical and Biophysical Research Communications, 1995
- Endothelin plays a role in the maintenance of blood pressure in normotensive guinea pigsLife Sciences, 1994
- Characterization of Contractile Endothelin and Angiotensin Receptors in Human Resistance Arteries: Evidence for Two Endothelin and One Angiotensin ReceptorBiochemical and Biophysical Research Communications, 1994
- Clearance of Circulating Endothelin-1 by ETB Receptors in RatsBiochemical and Biophysical Research Communications, 1994
- ETA and ETB Receptors Coexist on Rabbit Pulmonary Artery Vascular Smooth Muscle Mediating ContractionBiochemical and Biophysical Research Communications, 1993
- Renal actions of endothelinKidney International, 1993
- Molecular cloning of a non-isopeptide-selective human endothelin receptorBiochemical and Biophysical Research Communications, 1991
- Endothelin and the production of cerebral vasospasm in dogsBiochemical and Biophysical Research Communications, 1989